Pharma major Biological E has sought approval from drug regulator Drugs Controller General of India to conduct the phase-3 clinical trial of Covid vaccine Corbevax.
Kartik Aaryan was recently spotted by media outside a hospital in Mumbai after taking his final dose of Covid vaccine.
In Septemeber, the Drugs Controller General of India had granted permission for the conducting Phase 3 bridging trials of Sputnik Light on the Indian population.
WHO & an independent group of experts are scheduled to meet next week to carry out the risk/benefit assessment and come to a final decision whether to grant Emergency Use Listing to Covaxin.
This is a swarm of people jostling for COVID19 vaccines. These are visuals from outside Athagarh's Gurudijhatia Primary Health Care Centre in Cuttack.
Re-infections can and have happened, even shortly after recovery. And they will become increasingly common as immunity wanes and new SARS-CoV-2 variants arise.
The next phase of COVID-19 vaccination commenced from March 1 for people over 60 years and those aged 45 and above with specified co-morbid conditions.
Applying a tit-for-tat strategy, India on Friday decided to impose reciprocal Covid-19 restrictions on UK nationals arriving in the country.
There is no difference in antibodies produced by Covaxin and Covishield vaccines against the Covid-19 virus. This information was shared by Odisha Health Services Director Bijay Mohapatra on Monday (Sept 27).
The health department has targeted to vaccinate over 4 lakh people each day for which the inoculation drive is underway in 1,800 session sites in the State.
The antibody responses in the participants given 10 microgram doses were comparable to those recorded in a previous Pfizer-BioNTech study in people 16 to 25 years of age immunised with 30 microgram doses.
Union Health Minister on Monday said that India's vaccination drive has been a role model for the world and India will be resuming export of vaccines under 'Vaccine Maitri' to fulfil the commitment towards COVAX.
The bench said it will issue notice to the Union of India and sought its response in two weeks and also sought the assistance of Solicitor General Tushar Mehta to apprise the court about the policy which has been formulated for the vaccination of pregnant women and lactating mothers.
The outbreak of the Delta variant of Covid-19 in the southern province of Fujian has become a case of huge concern for the Chinese authorities. The number of cases is increasing at a rapid speed while the authorities are struggling to contain new infections.
It was unethical to start giving the third booster dose of Covid vaccine to someone when others in certain countries and populations have not even got two doses for full vaccination, said Adar Poonawalla on Friday
The study was conducted on at least 40,000 elderly people in Argentina. Sputnik Light also reduced hospitalizations among the target population at 82.1-87.6 per cent, the study said.
The findings showed that the currently available Covid-19 jabs provide strong protection for most people against hospitalisation and death, even during the delta surge. However, higher hospitalisation and death rates are observed in older age groups, regardless of vaccination status.
Almost 20-25 percent of fully inoculated population would not develop antibodies for Covid-19. This information was shared by Director of Institute of Life Sciences (ILS), Ajay Parida on Saturday (Sept 11).
The global health body is currently reviewing Bharat Biotech's application for an Emergency Use Listing of its COVID-19 vaccine Covaxin.
Moderna is developing vaccines against viral diseases including vaccines against acute respiratory infections, vaccines against persistent infections, as well as vaccines against threats to global public health.
The MHRA also noted that it is now up to the Joint Committee on Vaccination and Immunisation (JCVI), the UK vaccine advisory body, "to advise on whether booster jabs will be given and if so, which vaccines should be used".
The incidence of the side effect remains extremely rare, with only 833 cases reported worldwide from about 592 million administered doses of the adenovirus-based AstraZeneca vaccine, as of July 25.
Cumulatively, 27,64,10,694 people in the 18-44 age group have received their first dose and 3,57,76,726 the second dose since the start of Phase-3 of the vaccination drive.
Biological E has received the Drugs Controller General of Indias' (DCGI) approval for conducting Phase 3 comparator safety and immunogenicity trial of its Corbevax vaccine in adults after the subject expert committee's (SEC) review of Phase 1 and 2 clinical trials data.
India's vaccination coverage against coronavirus under the mass vaccination drive has crossed the landmark of 63 crore. Over 73 lakh doses have been administered in the last 24 hours.